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<ABSTRACT>
Effects of body composition, leptin and adiponectin on bone 
mineral density in prepubertal girls 
 
Young Jun Rhie 
 
Department of Medicine 
The Graduate School, Yonsei University  
 
(Directed by Professor Duk Hee Kim) 
 
 
The relationship between obesity and bone mineral density is not 
clear. Body weight is positively associated with bone mineral density. 
It has been a controversy whether lean mass or fat mass has more 
influence on bone stimulatory effect. Some adipokines seem to 
participate in bone metabolism. Leptin and adiponectin are potential 
independent contributors to bone mineral density. The aim of this study 
was to assess the relation among body composition, adipokines (leptin 
and adiponectin) and bone mineral density, and whether adipokines and 
body composition determine bone mineral density independently in 
prepubertal girls. Subjects included forty eight prepubertal girls. They 
were classified as obese and control groups according to their body 
mass index. Serum leptin and adiponectin levels were determined by 
enzyme immunoassay. Bone mineral density by dual energy X-ray 
absorptiometry and body composition by bioelectrical impedance 
analysis were measured. Lean mass was positively correlated with bone 
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mineral density. Fat mass was negatively correlated with L-spine bone 
mineral density after adjustment for body weight. Serum leptin levels 
were positively correlated with bone mineral density. Lean mass was a 
positive independent predictor of bone mineral density. Serum leptin 
was a positive independent predictor of femoral bone mineral density. 
Fat mass was found to be a negative independent predictor of femoral 
bone mineral density. Lean mass has favorable effect on bone mineral 
density. Fat mass seems not to be beneficial to the bone structure 
against osteoporosis, despite increased mechanical loading. Leptin may 
have a certain biological role in regulating bone metabolism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-------------------------------------------------------------------------------------- 
Key words: bone mineral density, body composition, leptin, 
adiponectin, obesity 
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I. INTRODUCTION 
 
Rapidly increasing childhood obesity has become a major public health 
concern. Obesity is a main risk factor for cardiovascular disease, diabetes, 
hypertension and cancer1-3. However, the relationship between obesity and 
bone mineral density (BMD) is unclear4.  
Childhood and adolescence are the most important period for maximum 
bone mass acquisition, associated with genetic potential, nutritional factors, 
physical activity and body composition5. Osteoporosis-related fracture risk is 
highly dependent on BMD6, 7. Body weight is positively associated with 
BMD8-10 and negatively associated with fracture incidence7, 11. However, it 
remains a controversy whether it is lean mass or adipose tissue that mediates 
the bone stimulatory effect exerted by weight12-14. Recent reports indicated 
that in young female populations, lean mass is a positive predictor15, 16, 
whereas adipose tissue is a weaker positive17, or a negative predictor of 
BMD16, 18, 19. Adipose tissue, once considered a metabolically passive fuel 
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depot for energy substrate, has recently become as a metabolically active 
tissue. It secretes a variety of proteins called adipokines into circulation, 
which play important roles in the modulation of biological functions. The 
relation between adipose tissue and BMD is credited not only to stress from 
mechanical loading but also to the metabolic effect of adipokines20. Leptin 
and adiponectin are potential contributors to BMD. Leptin is a satiety 
regulating hormone and have a central role not only regulating in energy 
expenditure, but also in bone metabolism4. Leptin increases the proliferation 
and differentiation of osteoblast in adults21. Adiponectin increases insulin 
sensitivity and may improve the lipid profiles22, 23. Serum adiponectin levels 
are negatively correlated with parameters of overall obesity24. It was 
suggested that high adiponectin levels may cause increased osteoclastic 
activity and low BMD25. Adiponectin, however, is also reported to increase 
osteoblastic activity and decrease osteoclastic activity in animals26.  
The relation between body composition, especially adipose tissue, and 
BMD in obese children is clinically important because any therapeutic 
interventions for obesity that modifies body composition may affect BMD and 
the risk of osteoporosis in later life. Few have attempted to investigate the 
effect of body composition and adipokines on BMD in children. Accordingly, 
I investigated the relation among body composition, leptin and adiponectin, 
and BMD, and whether adipokines and body composition determine BMD 
independently in prepubertal girls.  
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II. MATERIALS AND METHODS 
 
1. Subjects 
The Institutional Review Board at Korea University Ansan Hospital 
approved the study. Written informed consents were obtained from both 
subjects and parents. Forty eight children who visited department of pediatrics, 
Korea University Ansan Hospital due to obesity or non-endocrine disease 
participated in the study. All of the subjects were female and prepubertal. 
Pubertal stage was determined by a single pediatric endocrinologist according 
to the criteria of Tanner27. Children who showed pubertal development were 
excluded from the study. None of the subjects in this study had a medical 
history of cardiovascular disease, diabetes, hypertension and other endocrine 
disorders.  
 
2. Anthropometric measurement 
Height was measured to the nearest 0.1 cm using a rigid stadiometer. 
Weight was measured to the nearest 0.1 kg using a calibrated balance scale. 
Body mass index (BMI) was calculated as the weight in kilograms divided by 
the square of height in meters. Among the forty eight subjects, twenty three 
(BMI ≥ 95th percentile for age and sex, according to 2007 Korean national 
growth chart) were classified into obese group and twenty five (25th 
percentile ≤ BMI < 75th percentile, according to 2007 Korean national 
growth chart) into control group. 
 
3. Bone age assessment 
A standard left-hand wrist radiograph was obtained and bone age was 
determined by a single observer according to Greulich and Pyle method28, 
expressed in years. 
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4. Body composition assessment 
Body composition measurement was performed by bioelectrical impedance 
analysis, using InBody 4.0 (Biospace, Seoul, Korea). Fat and lean mass were 
expressed in kilograms. 
 
5. Bone mineral density assessment 
BMD was measured by a single technician by way of dual energy X-ray 
absorptiometry (DXA), using Expert version 1.90 (Lunar Corp., Madison, WI, 
USA). BMD of L2-L4 lumbar spine and femoral neck was evaluated, 
expressed in gram/centimeter2. 
 
6. Biochemical assessment 
Blood sampling was performed in the overnight fasting state. Serum insulin 
like growth factor-1 (IGF-1), insulin like growth factor binding protein-3 
(IGFBP-3), luteinizing hormone (LH), follicle stimulating hormone (FSH), 
estradiol, thyroid stimulating hormone (TSH), fT4, adrenocorticotropic 
hormone (ACTH), cortisol, parathyroid hormone (PTH), osteocalcin, insulin, 
glucose, total cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol, 
leptin and adiponectin were measured. Leptin levels were measured with 
enzyme immunoassay kit (ALPCO Diagnostics, Salem, NH, USA). 
Adiponectin levels were measured by enzyme immunoassay kit (AdipoGen, 
Inc., Seoul, Korea). Insulin resistance was estimated as homeostatic model 
assessment of insulin resistance (HOMA-IR), with the calculations as follows: 
HOMA-IR = [insulin (mU/l) x glucose (mmol/l)] / 22.5. 
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7. Statistical analysis 
Data are expressed as mean ± SD. Anthropometric and endocrine 
characteristics were compared between obese and control groups using an 
independent t-test. Serum glucose, insulin, HOMA-IR, leptin, adiponectin 
levels, body composition and bone mineral density were compared between 
obese and control groups using an independent t-test. The relationship 
between BMD and other metabolic variables was determined by Pearson’s 
correlation analysis and Partial correlation analysis. Multiple linear regression 
analysis was performed to investigate whether leptin, adiponectin, HOMA-IR 
and body composition determine BMD independently. The SPSS 12.0 
software was used for statistical analysis. P values < 0.05 were considered 
statistically significant.  
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III. RESULTS 
 
1. Anthropometric and endocrine characteristics  
Anthropometric and endocrine characteristics of obese and control groups 
are shown in Table 1. LH, FSH and estradiol levels of all the subjects were 
less than 0.07 IU/l, 1.00 IU/l and 10.0 pg/ml, respectively. Obese group had 
significantly higher weight and BMI compared with control group. There was 
no significant difference in age, height, bone age, IGF-1, IGFBP-3, TSH, fT4, 
ACTH, cortisol, PTH, osteocalcin levels and lipid profiles between the two 
groups. 
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Table 1. Anthropometric and endocrine characteristics of obese and control 
groups 
 Obese (n=23) Control (n=25) P 
Age (year) 8.3 ± 1.3 8.7 ± 1.2 0.242 
Height (cm) 133.5 ± 9.5 132.9 ± 10.1 0.819 
Weight (kg) 40.5 ± 7.5 30.7 ± 7.0 <0.05 
BMI (kg/m2) 22.5 ± 1.9 17.2 ± 1.5 <0.05 
Bone age (year) 10.5 ± 1.4 9.4 ± 1.1 0.194 
IGF-1 (ng/ml) 349.3 ± 140.8 377.3 ± 168.3 0.537 
IGFBP-3 (µg/ml) 3.49 ± 0.73 3.29 ± 0.81 0.378 
TSH (mIU/l) 3.31 ± 1.79 1.82 ± 0.87 0.075 
fT4 (ng/dl) 1.29 ± 0.18 1.34 ± 0.17 0.578 
ACTH (pg/ml) 28.16 ± 15.47 23.02 ± 9.44 0.469 
Cortisol (µg/ml) 13.15 ± 7.38 10.92 ± 4.99 0.516 
PTH (pg/ml) 27.08 ± 17.76 28.90 ± 16.66 0.837 
Osteocalcin (ng/ml) 68.06 ± 20.10 71.29 ± 15.46 0.735 
Total cholesterol (mg/dl) 174.5 ± 23.9 172.8 ± 26.8 0.817 
Triglyceride (mg/dl) 90.9 ± 47.3 95.3 ± 64.1 0.788 
HDL-cholesterol (mg/dl) 51.7 ± 8.0 58.4 ± 14.5 0.056 
LDL-cholesterol (mg/dl) 102.5 ± 20.9 93.0 ± 18.7 0.110 
Data are shown as mean ± SD.  
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2. Serum glucose, insulin, leptin, adiponectin levels, body composition 
and bone mineral density  
Serum glucose, insulin, leptin, adiponectin levels, body composition and 
bone mineral density of obese and control groups are shown in Table 2. Obese 
group had significantly higher serum leptin levels, fat mass, lean mass, 
femoral and L-spine BMD compared with control group. There was no 
significant difference in serum glucose, insulin, HOMA-IR and serum 
adiponectin levels between the two groups. 
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Table 2. Metabolic parameters, body composition and bone mineral density of 
obese and control groups 
 Obese (n=23) Control (n=25) P 
Glucose (mmol/l) 4.95 ± 0.29 5.02 ± 0.32 0.425 
Insulin (mIU/l) 15.13 ± 5.19 11.18 ± 2.93 0.091 
HOMA-IR 3.33 ± 1.24 2.40 ± 0.55 0.089 
Leptin (ng/ml) 15.04 ± 7.13 6.34 ± 4.90 <0.05 
Adiponectin (ng/ml) 10.06 ± 2.46 11.32 ± 2.45 0.081 
Fat mass (kg) 13.8 ± 3.8 7.0 ± 2.4 <0.05 
Lean mass (kg) 24.7 ± 4.1 20.2 ± 2.1 <0.05 
BMDfemur (g/cm2) 0.815 ± 0.098 0.665 ± 0.091 <0.05 
BMDL-spine (g/cm2) 0.789 ± 0.079 0.667 ± 0.071 <0.05 
Data are shown as mean ± SD. 
HOMA-IR: homeostatic model assessment of insulin resistance, BMDfemur: 
femoral bone mineral density, BMDL-spine: L-spine bone mineral density. 
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3. Relationship of serum leptin, adiponectin levels, HOMA-IR and body 
composition with bone mineral density 
The results of Pearson’s correlation and Partial correlation after adjustment 
for body weight of serum leptin, adiponectin levels, HOMA-IR and body 
composition with bone mineral density are shown in Table 3. Body weight 
was positively correlated with femoral and L-spine BMD. Serum leptin, 
HOMA-IR, fat and lean mass had significant positive correlations with 
femoral BMD, and they disappeared after adjustment for body weight. Serum 
adiponectin was not correlated with femoral BMD. Serum leptin and lean 
mass had significant positive correlations with L-spine BMD, and still 
remained significant after adjustment for body weight. There was significant 
positive correlation between fat mass and L-spine BMD, but it became 
negative after adjustment for body weight. HOMA-IR and serum adiponectin 
level were not correlated with L-spine BMD.  
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Table 3. Correlation of metabolic parameters and body composition with bone 
mineral density 
 BMDfemur BMDL-spine 
 Unadjusted Body weight, 
adjusted Unadjusted 
Body weight, 
adjusted 
Body weight 0.751*  0.761*  
Leptin  0.659* 0.128 0.481* 0.409* 
Adiponectin  -0.181 0.025 -0.006 0.292 
HOMA-IR 0.455* 0.080 0.353 -0.084 
Fat mass 0.750* -0.356 0.681* -0.578* 
Lean mass  0.818* 0.319 0.830* 0.490* 
Pearson’s correlation coefficients and Partial correlation coefficients after 
adjustment for body weight are presented.  
BMDfemur: femoral bone mineral density, BMDL-spine: L-spine bone mineral 
density, HOMA-IR: homeostatic model assessment of insulin resistance. 
*
 P<0.05 
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4. Serum leptin, adiponectin levels, HOMA-IR and body composition as 
independent predictors of bone mineral density 
The results of multiple linear regression analysis to investigate whether 
leptin, adiponectin and body composition determine BMD independently are 
shown in Table 4. Lean mass was found to be a positive independent predictor 
of femoral and L-spine BMD. Serum leptin was found to be a positive 
independent predictor of femoral BMD but not of L-spine BMD. Fat mass 
was found to be a negative independent predictor of femoral BMD but not of 
L-spine BMD. Serum adiponectin and HOMA-IR were not independent 
predictors of BMD. 
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Table 4. Serum leptin, adiponectin levels, HOMA-IR and body composition 
as independent predictors of bone mineral density 
 BMDfemur BMDL-spine 
 β P β P 
Leptin  0.555 <0.05 -0.024 0.918 
Adiponectin  -0.040 0.743 0.042 0.768 
HOMA-IR 0.090 0.495 0.034 0.820 
Fat mass -0.593 <0.05 -0.109 0.740 
Lean mass  0.979 <0.05 0.907 <0.05 
Results of multiple linear regression analyses including serum leptin, 
adiponectin , HOMA-IR, fat and lean mass on bone mineral density. 
Standardized β and P values are presented. 
BMDfemur:femoral bone mineral density, BMDL-spine:L-spine bone mineral 
density, HOMA-IR:homeostatic model assessment of insulin resistance. 
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IV. DISCUSSION 
 
In this study, I was able to demonstrate higher BMD in obese than control 
group children. This finding supports a positive relationship between body 
weight and BMD in the previous studies8-10. BMD of obese subject can be 
influenced by increased body weight. The bone structure can easily adapt to 
stimuli. Excessive weight produces a mechanical force on the bones, 
stimulating osteogenesis29.  
Obesity is characterized by increased body weight with excess body fat and 
a relative increase of lean mass. It has been a controversy whether lean mass 
or fat mass has more influence on bone stimulatory effect12-14. Previous 
studies indicated that regardless of age or gender, lean mass has a strong 
positive influence on BMD17, 30, 31. However, the results of previous studies on 
the relation between fat mass and BMD were conflicting. Adipose tissue is a 
weaker positive predictor17 or even stronger predictor10, 14 than lean mass, or 
even a negative predictor of BMD18, 19.  
This study indicates that lean mass is positively correlated with BMD and a 
positive independent predictor of BMD, whereas fat mass is negatively 
correlated with L-spine BMD after adjustment for body weight. This finding 
is consistent with previous reports suggesting that bone strengths is primarily 
determined by dynamic loads from muscle force, not static loads, such as fat 
mass31. I also found that fat mass was a negative independent predictor of 
femoral BMD after multiple linear regression analysis. It seems that the 
contribution of fat mass offset its potential benefit as a mechanical load. The 
basis for negative effect of fat mass on the bone mass observed in this study is 
unknown. 
Adipose tissue is not a metabolically passive fuel depot for energy substrate 
anymore. It has become a metabolically active tissue, secreting a variety of 
adipokines that modulate biological functions. It is suggested that some 
 17 
adipokines participate in bone metabolism. Leptin and adiponectin are 
potential contributors to BMD.  
Leptin has been proposed to be a mediator of adipose tissue hormonal 
effect on bone mass4. The role of leptin in bone metabolism is not fully 
understood, but animal studies showed the ‘high bone mass phenotype’ in the 
leptin deficient mice32. In humans, some studies4, 33, 34 have failed to show any 
association between serum leptin levels and BMD in women or in men, 
whereas others have reported a positive association between leptin and 
BMD35. In a few recent studies36, 37, leptin was negatively correlated with 
BMD. In this study, I showed that serum leptin levels were positively 
correlated with both femoral and L-spine BMD, and leptin was an 
independent positive predictor of femoral BMD.  
Adiponectin acts directly on bone to induce human osteoblast proliferation 
and differentiation, and to increase osteoclast formation indirectly25, 38. 
Another previous study39 showed that adiponectin exerted a negative 
independent effect on BMD. Some studies also reported that there were no 
independent relationship between adiponectin and BMD40, 41. I was not able to 
show any correlation between adiponectin and BMD.  
Another link between obesity and BMD is insulin. Insulin reduces the 
hepatic synthesis of sex hormone carriers. Thus, there is an increase in free 
form sex hormones, which stimulates the activity of osteoblasts42. I found that 
HOMA-IR had a weak positive correlation with femoral BMD, but no 
significant correlation with L-spine BMD. 
This study was limited to prepubertal girls to control other factors that 
affect BMD. In puberty, growth hormone and sex steroid actively participate 
in the bone structure development as a result of normal growth5. Sex seems to 
be an important determinant of BMD, probably because of different muscle 
and sex steroid level in boys and girls43. 
It should be noted that this cross sectional study limits the interpretation of 
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the results, especially with regard to cause-effect interactions. Another limit of 
this study is the fact that we did not include male and pubertal subject and I 
did not control the life style of subjects such as calcium diet and exercise. 
In conclusion, in prepubertal girls, lean mass has favorable effect on BMD. 
Lean mass is a positive independent predictors of femoral and L-spine BMD. 
Fat mass is a negative independent predictor of femoral BMD. Fat mass 
seems not to be beneficial to the bone structure against osteoporosis, despite 
increased mechanical loading. Leptin can predict femoral BMD independently. 
Leptin may have a certain biological role in regulating bone metabolism. 
Further prospective study including male and pubertal subjects is necessary to 
apply our findings to general populations. 
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V. CONCLUSION 
 
I assessed the effects of body composition, leptin and adiponectin on bone 
mineral density in prepubertal girls. Lean mass is more favorable to the bone 
mass than fat mass against osteoporosis. Leptin may have a certain biological 
role in regulating bone metabolism. 
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< ABSTRACT (IN KOREAN) > 
사춘기이전 여아에서 체성분, 렙틴, 아디포넥틴의 골밀도에 
대한 영향 
 
<지도교수  김덕희> 
 
연세대학교 대학원 의학과 
 
이영준 
 
 
비만과 골밀도의 상관 관계는 명확하지 않다. 체중은 
골밀도와 양의 상관 관계가 있다. 그러나, 제지방과 체지방 
중 어느 것이 골밀도에 더 영향을 끼치는지에 대해서는 
논란의 여지가 많다. 어떤 지방세포에서 분비되는 호르몬은 
골대사에 직접 관계되는 것으로 보인다. 렙틴과 아디포넥틴은 
골밀도에 독립적으로 영향을 주는 것으로 보인다. 본 연구의 
목적은 체성분과 렙틴, 아디포넥틴의 골밀도에 대한 영향을 
알아보고, 체성분과 렙틴, 아디포넥틴이 골밀도에 독립적인 
영향을 주는지 확인해 보는 것이다. 대상 환아는 모두 48명의 
사춘기 이전 여아로 구성되었다. 이들은 체질량지수에 의해 
비만군과 대조군으로 분류되었다. 혈중 렙틴, 아디포넥틴 
농도를 효소면역 측정법으로 측정하였다. 체성분은 생체전기 
임피던스법으로, 골밀도는 이중 에너지 방사선 흡수법으로 
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측정하였다. 제지방은 골밀도와 양의 상관 관계가 있었다. 
체지방은 체중을 통제한 후 요추 골밀도와 음의 상관 관계가 
있었다. 혈중 렙틴 농도는 골밀도와 양의 상관 관계가 있었다. 
제지방은 골밀도에 대해 독립적인 양의 예측자로 판명되었다. 
혈중 렙틴 농도는 대퇴 골밀도에 대한 독립적인 양의 
예측자였다. 체지방은 대퇴 골밀도에 대한 독립적인 음의 
예측자였다. 제지방은 골밀도에 유익한 영향을 끼치며, 
체지방은 물리적인 부하에도 불구하고 골밀도에 유익하지 
않는 것으로 보인다. 렙틴은 골대사의 조절에 특정한 
생물학적 역할을 하는 것으로 생각된다.  
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